Polish clinics utilize both autologous and allogeneic stem cells. Autologous cells, harvested from a patient’s own bone marrow or fat tissue, typically treat orthopedic conditions. Allogeneic treatments use donor cells, often from umbilical cord Wharton’s jelly, for systemic issues, autoimmune disorders, and pediatric malignancies.
- Autologous source: Cells are typically extracted from the patient's own bone marrow or adipose tissue.
- Allogeneic source: Donor options include family matches, unrelated registries, or umbilical cord tissue (Wharton's jelly).
- Orthopedic application: Surgeons like Dr. Andrzej Komor at Carolina Hospital use stem cells for joint repair.
- Clinical diversity: Facilities like KCM Clinic offer specialized packages for international patients seeking regenerative therapies.
Bookimed Expert Insight: While autologous cells are often marketed for safety, data shows they require 1–2 weeks longer for processing. Clinics like Carolina Hospital, which serves the Polish Olympic Committee, emphasize precise harvesting. Patients should confirm if marrow extraction fees are bundled or charged as separate surgical procedures.
Patient Consensus: Many patients recommend requesting written confirmation of the cell processing method before payment. Some noted that autologous treatments require extra appointments for harvesting, which can extend the overall travel timeline.